Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? 1992

P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
Mersey Regional Department of Medical and Surgical Neurology, Walton Hospital, Liverpool.

A total of 276 patients with a high risk of developing postoperative seizures were randomised to treatment with carbamazepine or phenytoin for six or 24 months, or to no treatment. No significant differences were found (though the confidence limits were fairly wide) between the regimes in respect of the incidence of seizures or death. In a substantial proportion of the patients postoperative epilepsy remained a continuing disability. A high incidence of drug-related side effects was found in the treatment groups. Prophylactic anticonvulsants cannot therefore be recommended routinely following supratentorial craniotomy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D003399 Craniotomy Surgical incision into the cranium. Craniectomy,Craniectomies,Craniotomies
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
April 1991, Journal of the Royal Society of Medicine,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
January 1981, Acta neurologica Scandinavica. Supplementum,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
August 2018, Journal of neurosurgical sciences,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
September 1967, European journal of pharmacology,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
January 1988, Polish journal of pharmacology and pharmacy,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
April 1962, Indian journal of physiology and pharmacology,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
January 1981, Acta neurologica Scandinavica. Supplementum,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
February 2013, The Cochrane database of systematic reviews,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
March 2015, The Cochrane database of systematic reviews,
P M Foy, and D W Chadwick, and N Rajgopalan, and A L Johnson, and M D Shaw
April 1982, Scottish medical journal,
Copied contents to your clipboard!